Public Employees Retirement System of Ohio Boosts Stock Holdings in CareDx Inc (NASDAQ:CDNA)

Public Employees Retirement System of Ohio grew its position in shares of CareDx Inc (NASDAQ:CDNA) by 15.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 126,100 shares of the company’s stock after buying an additional 17,300 shares during the quarter. Public Employees Retirement System of Ohio owned 0.30% of CareDx worth $4,538,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently bought and sold shares of CDNA. Wells Fargo & Company MN raised its position in CareDx by 4.4% in the second quarter. Wells Fargo & Company MN now owns 727,673 shares of the company’s stock worth $26,189,000 after acquiring an additional 30,566 shares during the period. Redwood Investments LLC lifted its stake in CareDx by 23.0% in the second quarter. Redwood Investments LLC now owns 438,407 shares of the company’s stock worth $15,778,000 after purchasing an additional 81,932 shares during the last quarter. Renaissance Technologies LLC lifted its stake in CareDx by 24.6% in the second quarter. Renaissance Technologies LLC now owns 332,800 shares of the company’s stock worth $11,977,000 after purchasing an additional 65,600 shares during the last quarter. Kornitzer Capital Management Inc. KS lifted its stake in CareDx by 29.0% in the second quarter. Kornitzer Capital Management Inc. KS now owns 309,655 shares of the company’s stock worth $11,144,000 after purchasing an additional 69,535 shares during the last quarter. Finally, Cortina Asset Management LLC lifted its stake in CareDx by 27.5% in the second quarter. Cortina Asset Management LLC now owns 279,306 shares of the company’s stock worth $10,052,000 after purchasing an additional 60,254 shares during the last quarter. Hedge funds and other institutional investors own 92.82% of the company’s stock.

In related news, CEO Peter Maag sold 50,000 shares of the company’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $28.84, for a total value of $1,442,000.00. Following the completion of the transaction, the chief executive officer now directly owns 379,049 shares in the company, valued at $10,931,773.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Sasha King sold 9,542 shares of the company’s stock in a transaction on Monday, July 1st. The stock was sold at an average price of $35.74, for a total transaction of $341,031.08. Following the completion of the transaction, the insider now owns 62,045 shares of the company’s stock, valued at $2,217,488.30. The disclosure for this sale can be found here. Insiders have sold a total of 125,084 shares of company stock valued at $4,288,055 over the last 90 days. Company insiders own 3.20% of the company’s stock.

CDNA has been the subject of a number of research analyst reports. Craig Hallum set a $48.00 price objective on shares of CareDx and gave the company a “positive” rating in a report on Thursday, July 11th. Zacks Investment Research upgraded shares of CareDx from a “sell” rating to a “hold” rating in a report on Wednesday, August 7th. HC Wainwright set a $43.00 price target on shares of CareDx and gave the company a “buy” rating in a report on Friday, August 23rd. Piper Jaffray Companies set a $63.00 price target on shares of CareDx and gave the company a “buy” rating in a report on Thursday, August 22nd. Finally, TheStreet lowered shares of CareDx from a “c” rating to a “d” rating in a report on Thursday, May 23rd. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. CareDx presently has an average rating of “Buy” and a consensus price target of $44.00.

CareDx stock traded up $0.69 during mid-day trading on Friday, reaching $22.65. The company’s stock had a trading volume of 23,069 shares, compared to its average volume of 695,244. The firm’s fifty day moving average price is $26.01 and its two-hundred day moving average price is $31.27. The company has a market capitalization of $848.95 million, a P/E ratio of -17.47 and a beta of 1.04. CareDx Inc has a 12-month low of $19.11 and a 12-month high of $41.27.

CareDx (NASDAQ:CDNA) last released its quarterly earnings results on Thursday, August 1st. The company reported ($0.19) EPS for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.07). The firm had revenue of $31.45 million for the quarter, compared to analysts’ expectations of $27.96 million. CareDx had a negative net margin of 38.29% and a negative return on equity of 47.53%. Equities analysts expect that CareDx Inc will post -0.7 EPS for the current fiscal year.

About CareDx

CareDx, Inc operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Read More: Understanding Options Trading

Want to see what other hedge funds are holding CDNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CareDx Inc (NASDAQ:CDNA).

Institutional Ownership by Quarter for CareDx (NASDAQ:CDNA)

Receive News & Ratings for CareDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareDx and related companies with MarketBeat.com's FREE daily email newsletter.